Benitec Biopharma Inc. (BNTC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Benitec Biopharma Inc.

    NASDAQ: BNTC · Real-Time Price · USD
    13.70
    -0.10 (-0.72%)
    At close: Sep 26, 2025, 3:59 PM
    13.70
    0.00%
    After-hours: Sep 26, 2025, 04:10 PM EDT

    Benitec Biopharma Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 n/a 216K 75K 73K 59K
    Cost of Revenue
    		 396K 108K 381K 9K 123K
    Gross Profit
    		 -396K 108K -306K 64K -64K
    Operating Income
    		 -41.77M -22.49M -19.08M -17.85M -13.6M
    Interest Income
    		 3.29M 904K n/a n/a n/a
    Pretax Income
    		 -37.92M -21.75M -19.56M -18.21M -13.88M
    Net Income
    		 -37.92M -21.75M -19.56M -18.21M -13.88M
    Selling & General & Admin
    		 23.43M 6.99M 6.38M 6.65M 6.51M
    Research & Development
    		 18.33M 15.61M 12.77M 11.27M 7.02M
    Other Expenses
    		 -396K -216K n/a n/a n/a
    Operating Expenses
    		 41.37M 22.38M 19.16M 17.92M 13.53M
    Interest Expense
    		 n/a n/a 33K 32K 6K
    Selling & Marketing Expenses
    		 n/a 277K n/a n/a n/a
    Cost & Expenses
    		 41.77M 22.49M 19.16M 17.93M 13.65M
    Income Tax Expense
    		 n/a -619K 3K 354K n/a
    Shares Outstanding (Basic)
    		 36.21M 10.26M 1.39M 1.92M 1.01M
    Shares Outstanding (Diluted)
    		 36.21M 10.28M 1.39M 1.92M 1.01M
    EPS (Basic)
    		 -1.05 -2.68 -14.12 -19.31 -27.27
    EPS (Diluted)
    		 -1.05 -2.68 -14.12 -19.31 -27.27
    EBITDA
    		 -41.77M -21.41M -19.15M -17.85M -13.45M
    EBIT
    		 -41.77M -21.75M -19.53M -18.18M -13.88M
    Depreciation & Amortization
    		 69.33K 343K 381K 392K 424K

    Add to Watchlist